Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 26, 2015, 32 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $470.00 to $2,120,132.50.

Highlighted Stocks Traded by Insiders:

Clearfield (CLFD) - FREE Research Report

Hill John P, who is Chief Operating Officer at Clearfield, sold 10,000 shares at $12.02 on Jan. 26, 2015. Following this transaction, the Chief Operating Officer owned 239,069 shares meaning that the stake was reduced by 4.01% with the 10,000-share transaction.

The shares most recently traded at $12.09, up $0.07, or 0.62% since the insider transaction. Historical insider transactions for Clearfield go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 15,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 50,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 59,500

The average volume for Clearfield has been 61,900 shares per day over the past 30 days. Clearfield has a market cap of $164.1 million and is part of the technology sector and telecommunications industry. Shares are down 1.62% year-to-date as of the close of trading on Monday.

Clearfield, Inc. manufactures, markets, and sells standard and custom passive connectivity products to the fiber-to-the-premises (FTTP), large enterprises, and original equipment manufacturers markets in the United States. The company has a P/E ratio of 29.9. Currently, there is 1 analyst who rates Clearfield a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLFD - FREE

TheStreet Quant Ratings rates Clearfield as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Clearfield Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

FXCM (FXCM) - FREE Research Report

Romersa Michael, who is 10% Owner at FXCM, sold 363,807 shares at $2.71 on Jan. 26, 2015. Following this transaction, the 10% Owner owned 0 shares meaning that the stake was reduced by 100% with the 363,807-share transaction.

The shares most recently traded at $2.33, down $0.38, or 16.22% since the insider transaction. Historical insider transactions for FXCM go as follows:

  • 4-Week # shares bought: 7,500
  • 4-Week # shares sold: 72,130
  • 12-Week # shares bought: 7,500
  • 12-Week # shares sold: 367,037
  • 24-Week # shares bought: 7,500
  • 24-Week # shares sold: 629,937

The average volume for FXCM has been 7.6 million shares per day over the past 30 days. FXCM has a market cap of $111.8 million and is part of the financial sector and financial services industry. Shares are down 85.27% year-to-date as of the close of trading on Monday.

FXCM Inc., through its subsidiaries, provides online foreign exchange (FX) trading and related services to retail and institutional customers worldwide. It operates in two segments, Retail Trading and Institutional Trading. The stock currently has a dividend yield of 10.13%. The company has a P/E ratio of 23.7. Currently, there are no analysts who rate FXCM a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FXCM - FREE

TheStreet Quant Ratings rates FXCM as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and poor profit margins. Get the full FXCM Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Salesforce.com (CRM) - FREE Research Report

Norton Burke F, who is EVP and Chief Legal Officer at Salesforce.com, sold 5,000 shares at $58.58 on Jan. 26, 2015. Following this transaction, the EVP and Chief Legal Officer owned 47,701 shares meaning that the stake was reduced by 9.49% with the 5,000-share transaction.

The shares most recently traded at $57.31, down $1.27, or 2.21% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 220,000
  • 12-Week # shares sold: 608,165
  • 24-Week # shares sold: 1.5 million

The average volume for Salesforce.com has been 4.7 million shares per day over the past 30 days. Salesforce.com has a market cap of $37.0 billion and is part of the technology sector and computer software & services industry. Shares are up 0.79% year-to-date as of the close of trading on Monday.

salesforce.com, inc. provides enterprise cloud computing solutions to various businesses and industries worldwide. Currently, there are 24 analysts who rate Salesforce.com a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings rates Salesforce.com as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Salesforce.com Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null